Trial Profile
Effect of ibrutinib given either alone or in combination with rituximab or bendamustine in patients with Chronic Lymphocytic Leukemia and having complex metaphase karyotype and del(17p)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary) ; Bendamustine; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 11 May 2015 New trial record